University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center is a specialist cancer hospital and research institute in Houston's Texas Medical Center, founded in 1941. It is a University of Texas academic medical center, not a comprehensive university.

Graduate training runs through joint biomedical programs with UTHealth Houston and through MD Anderson departments in cancer biology, immunology, genetics, and quantitative sciences. Research hospitals and core laboratories for genomics, imaging, and immunotherapy sit on the same grounds.

Trainees number in the hundreds of graduate students, postdoctoral fellows, and residents rather than a large undergraduate body. Faculty physicians and scientists number in the thousands, with a large international laboratory workforce. Immunologist James P. Allison received the 2018 Nobel Prize in Physiology or Medicine while at MD Anderson.

Doctoral study is laboratory dissertation work under a principal investigator. Stipends and training grants support students in the Medical Center district south of downtown Houston.

In the Grad School Navigator directory, University of Texas MD Anderson Cancer Center lists 3 graduate programs in biology and public health, all of them doctoral programs.